4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000078
Chief Scientific Officer sold 6,500 shares at $5.89 ($38,285)
- Chief Scientific Officer acquired 6,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-28 | Exercise or conversion : show line 1 in the form | +6,500 | $0.06 | $390 | 6,500 | D |
| 2025-07-28 | Sale : show line 2 in the form | −6,500 | $5.89 | $38,285 | 0 | D |
| Open-market sales · 6,500 sh · avg $5.89 · $38,285 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-28 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −6,500 | 488,686 | D |
Loading xslF345X05/wk-form4_1753783796.xml…